Zee Media BureauNew Delhi: Pharma major Lupin Limited Friday announced that its US-based subsidiary Lupin Pharmaceuticals, Inc has got approval from the US health regulator to sell a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market. Lupin Pharmaceuticals Inc has received final approval from US Food and Drug Administration (USFDA) for its Rifampin Capsules in 150 mg and 300 mg strengths, Lupin Ltd said in a statement.
`Govt plans Waterport Authority of India`
Hearing on Anderson-Jadeja spat set for Aug 1
ATM paper-slip receipt can cause cancer: Study
Don`t take us for granted, NCP warns Congress